1. Erlotinib/osimertinib
   , 2020, Reactions Weekly CrossRef
2. Biopsy and re-biopsy for PD-L1 expression in NSCLC. association between PD-L1 and checkpoint inhibitor efficacy through treatment in NSCLC. A pilot study
   Paul Zarogoulidis et al, 2021, Expert Review of Respiratory Medicine CrossRef
3. Current knowledge of small cell lung cancer transformation from non-small cell lung cancer
   Giuseppe Giaccone et al, 2023, Seminars in Cancer Biology CrossRef
4. Mitochondrial VDAC1 Silencing in Urethane-Induced Lung Cancer Inhibits Tumor Growth and Alters Cancer Oncogenic Properties
   Nataly Melnikov et al, 2024, Cancers CrossRef
5. Transformation of epidermal growth factor receptor mutated lung adenocarcinoma to small-cell carcinoma long after the cessation of tyrosine kinase inhibitor treatment: A case series and literature review
   Kenya Miyamoto et al, 2024, Respiratory Medicine Case Reports CrossRef